Basic Materials / Specialty ChemicalsJakarta
$770.00
-15.00 (-1.91%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $152.6B · quality 47.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.13T
P/E
7.9x
↓EV/EBITDA
5.3x
↓ROE
4.9%
↑Gross Margin
15.7%
↓Debt/Equity
0.44
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.8%
FCF CAGR
—
FCF margin
-1.0%
FCF / Net income
-0.60x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.80T · net income $149.45B · FCF $-89.85B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8799.18B | $8799.18B | $7722.38B | $7316.90B | $7879.11B |
| Net Income | $149.45B | $149.45B | $220.36B | $160.94B | $321.01B |
| EBITDA | $425.03B | $425.03B | $470.26B | $378.95B | $624.52B |
| EPS | 99.00 | 99.00 | 146.00 | 104.00 | 206.00 |
| Gross Margin | 15.7% | 15.7% | 17.6% | 16.2% | 19.1% |
| Operating Margin | 5.0% | 5.0% | 5.3% | 5.3% | 7.6% |
| Net Margin | 1.7% | 1.7% | 2.9% | 2.2% | 4.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.44 | 0.44 | 0.41 | 0.38 | 0.51 |
| Current Ratio | 1.20 | 1.20 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-89.85B | $-89.85B | $152.63B | $516.78B | $199.50B |
| Returns | |||||
| ROE | 4.9% | 4.9% | 7.7% | 6.0% | 11.9% |
| Valuation | |||||
| P/E | 7.86 | 7.86 | 6.95 | 12.84 | 6.41 |
| EV/EBITDA | 5.25 | 5.25 | 5.18 | 7.19 | 5.11 |
| P/B | 0.38 | 0.38 | 0.53 | 0.77 | 0.76 |
| Growth & Yield | |||||
| Revenue Growth | 13.9% | 13.9% | 5.5% | -7.1% | — |
| EPS Growth | -32.2% | -32.2% | 40.4% | -49.5% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-11.6%
EPS terminal req.
$68.32
Spread vs growth
-20.6%
5Y implied EPS CAGR
-3.5%
EPS terminal req.
$82.67
Spread vs growth
-28.7%
10Y implied EPS CAGR
3.0%
EPS terminal req.
$133.15
Spread vs growth
-35.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-14.9%
Start / end P/E
6.5x → 7.8x
EPS bridge
146.00 → 99.00
Residual
-6.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.